Abatacept treatment is safe in patients with steroid-refractory sarcoidosis

by B C Frye, I Pink, I C Rump, W Meschede, T Schlaich, J Kappes, B Grimbacher, F Schubach, G Ihorst, K Höhne, D Stolz, G Zissel (+2 others)

Released as a paper-conference in Pneumologie by Georg Thieme Verlag.

2022

There are no accessible files associated with this release. You could check other releases for this work for an accessible version.

"Dark" Preservation Only

Save Paper Now!

Know of a fulltext copy of on the public web? Submit a URL and we will archive it

Type paper-conference
Stage

unknown

Year 2022

DOI 10.1055/s-0042-1747755

Container Metadata
Not in DOAJ
In Keepers Registry
ISSN-L: 0934-8387

Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)

Cite This

BibTeX
CSL-JSON
MLA
Harvard

Lookup Links

oaDOI/unpaywall (OA fulltext)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar

Catalog Record
Revision: 2a26596b-81e8-43de-9f7a-a8f320cddd23
API URL: JSON

Abatacept treatment is safe in patients with steroid-refractory sarcoidosis release_k3g7747fhnbp3otsvpyjqzg6jy